The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Real-world enfortumab vedotin +/- pembrolizumab (EV+/-P)–based treatment toxicity, treatment discontinuation, and associations with survival in advanced urothelial carcinoma (aUC).

Martin  Kurian

No Relationships to Disclose

Vivek  Nimgaonkar

Employment - Valar Labs

Omar  Elghawy

No Relationships to Disclose

Ronac  Mamtani

Honoraria - Flatiron Health

Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Merck; Seattle Genetics/Astellas

Research Funding - Astellas Pharma (Inst); Merck

Expert Testimony - King and Spalding LLP; McBrayer Firm